A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

2013404 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Investigational New Drugs

Volume 32, Issue 1, pp. 178-187

Field-Weighted Citation Impact: 9.44